Skip to content

Boundless Bio, Inc.

BOLD

CIK 0001782303 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$58.87M
+11.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.63
+32.5% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$57.6M
Q1 May 2026
Cash
$17.48M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
22.46M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings